Impact of the COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region, March to November 2020-Reference-Cited by-同舟云学术

Impact of the COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region, March to November 2020

Published:2021-06-17 Issue:24 Volume:26 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Maurer Florian P¹²^ORCID,Shubladze Natalia³,Kalmambetova Gulmira⁴,Felker Irina⁵,Kuchukhidze Giorgi⁶,Drobniewski Francis⁷,Yedilbayev* Askar⁶,Ehsani Soudeh⁶,

Affiliation:

1. Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

2. National and WHO Supranational Reference Laboratory for Mycobacteria, Research Center Borstel, Leibniz Lung Center, Borstel, Germany

3. National Reference Laboratory, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia

4. National TB Reference Laboratory, Bishkek, Kyrgyzstan

5. Scientific department, Novosibirsk Tuberculosis Research Institute, Novosibirsk, Russia

6. Regional Office for Europe, World Health Organization, Copenhagen, Denmark

7. Infectious Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom

Abstract

We assessed the impact of COVID-19 on diagnostic services for tuberculosis (TB) by national reference laboratories in the WHO European Region. Of 35 laboratories, 30 reported declines in TB sample numbers, amounting up to > 50% of the pre-COVID-19 volumes. Sixteen reported reagent or consumable shortages. Nineteen reallocated ressources to SARS-CoV-2 testing, resulting in an overall increase in workload, largely without a concomitant increase in personnel (n = 14). This poses a risk to meeting the 2025 milestones of the End TB Strategy.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference18 articles.

1. Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe.;Nikolayevskyy;Eur Respir J,2021

2. Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020.;Simões;Euro Surveill,2020

3. World Health Organization (WHO). WHO Global Tuberulosis Report 2020. Geneva: WHO; 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf

4. World Health Organization (WHO). Information Note Tuberculosis and COVID-19. Geneva: WHO. [Accessed: 25 Mar 2021]. Available from: https://www.who.int/news/item/15-12-2020-updated-who-information-note-ensuring-continuity-of-tb-services-during-the-covid-19-pandemic

5. World Health Organization Regional Office for Europe. Rapid communication on the role of the GeneXpert® platform for rapid molecular testing for SARS-CoV-2 in the WHO European Region. Copenhagen: WHO Regional Office for Europe. [Accessed: 25 Mar 2021]. Available from: https://www.euro.who.int/en/health-topics/communicable-diseases/tuberculosis/publications/2020/rapid-communication-on-the-role-of-the-genexpert-platform-for-rapid-molecular-testing-for-sars-cov-2-in-the-who-european-region-2020-produced-by-whoeurope

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The global impact of COVID-19 on tuberculosis: A thematic scoping review, 2020–2023;PLOS Global Public Health;2024-07-03

2. Impact of the COVID-19 pandemic on the real-world diagnostic infrastructure for tuberculosis—An ESGMYC collaborative study;PLOS ONE;2024-04-16

3. PASS to End TB in Europe: Accelerated efforts on prevention and systematic screening to end tuberculosis in the WHO European Region by 2030;International Journal of Infectious Diseases;2024-04

4. The Global Impact of COVID-19 on Tuberculosis: A Thematic Scoping Review, 2020-2023;2024-03-06

5. Diagnostic Capacities for Multidrug-Resistant Tuberculosis in the World Health Organization European Region;The Journal of Molecular Diagnostics;2022-11